The world's first phase III study of a regenerative medicine product targeting heart failure - the C ongestive H eart F A ilure Cardiopoietic R egenerative T herapy trial - has been initiated in Europe.
http://www.formkit.com/Daily/DailyDetail.cfm?chosen=66821
http://www.formkit.com/Daily/DailyDetail.cfm?chosen=66821
No comments:
Post a Comment